Evidence map›Paper›PMID 36894874›Full record

ArticleBMC cancer2023

The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer.

Honglei Zhang, Xiuting Wang, Yaqin Li, Ying Bai, Qi Li, Shuling Wang, Yimiao Wei, Jiarong Li, Songquan Wen, Weihong Zhao

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Recent advances in the regulation of CD47 by non-coding RNAs and its therapeutic potential in cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Honglei Zhang *Pathology and Pathophysiology Department, Basic Medical College, Shanxi Medical University, Taiyuan, 030001, China.
Xiuting Wang *Biochemistry and Molecular Biology Department, Basic Medical College, Shanxi Medical University, Taiyuan, 030001, China.
Yaqin LiThe Second Clinical Medical College, Shanxi Medical University, Taiyuan, 030001, China.
Ying BaiThe Second Clinical Medical College, Shanxi Medical University, Taiyuan, 030001, China.
Qi LiThe Second Clinical Medical College, Shanxi Medical University, Taiyuan, 030001, China.
Shuling WangDepartment of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Yimiao WeiThe Second Clinical Medical College, Shanxi Medical University, Taiyuan, 030001, China.
Jiarong LiDepartment of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Songquan WenThe Second Clinical Medical College, Shanxi Medical University, Taiyuan, 030001, China.
Weihong ZhaoDepartment of Obstetrics and Gynecology, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, China. sydeyzwh@sxmu.edu.cn.
Shanxi Medical University · CNSecond Hospital of Shanxi Medical University · CN

Funding

China Postdoctoral Science Foundation 2019M651072National Natural Science Foundation of China 81702583Outstanding Youth Fund Project of Shanxi Province 201901D211506Research Project Supported by Shanxi Scholarship Council of China 2022-195
6 · The paper itself

Abstract

backgroundOur previous studies have confirmed that miR-154-5p can regulate pRb expression, and thus, play a tumor suppressor role in HPV16 E7-induced cervical cancer. However, its upstream molecules have not been elucidated in the progression of cervical cancer. This study aimed to explore the role of the miR-154-5p upstream molecule, hsa_circ_0000276 in cervical cancer development and its possible mechanisms of action.

methodsWe detected differences in whole transcriptome expression profiles of cervical squamous carcinoma and tissues adjacent to cervical cancer tissues from patients using microarray technology to predict circular RNAs (circRNAs) with binding sites to miR-154-5p. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect the expression of hsa_circ_0000276 (which had the strongest binding capacity to miR-154 and was selected as the target molecule) in cervical cancer tissues, followed by in vitro functional assays. Downstream microRNAs (miRNAs) and mRNAs of hsa_circ_0000276 were identified using transcriptome microarray data and databases, while the protein-protein interaction networks were obtained using STRING. A competing endogenous RNA (ceRNA) network centered on hsa_circ_0000276 was constructed using Cytoscape and GO and KEGG databases. Abnormal expression and prognosis of critical downstream molecules were analyzed using gene databases and molecular experiments. qRT-PCR and western blot analysis was performed to verify the expression of candidate genes.

resultsWe identified 4,001 differentially expressed circRNAs between HPV16-positive cervical squamous carcinoma and benign cervical tissues and 760 circRNAs targeting miR-154-5p, including hsa_circ_0000276. hsa_circ_0000276 and miR-154-5p directly bound, and hsa_circ_0000276 was upregulated, in cervical precancerous lesions and cervical cancer tissues and cells. Silencing hsa_circ_0000276 inhibited G1/S transition and cell proliferation and promoted apoptosis in SiHa and CaSki cells. Bioinformatics analysis showed that the hsa_circ_0000276 ceRNA network included 17 miRNAs and seven mRNAs, and downstream molecules of hsa_circ_0000276 were upregulated in cervical cancer tissues. These downstream molecules were associated with a poor prognosis and affected cervical cancer-associated immune infiltration. Of these, expression of CD47, LDHA, PDIA3, and SLC16A1 was downregulated in sh_hsa_circ_0000276 cells.

conclusionsOur findings show that hsa_circ_0000276 exerts cancer-promoting effects in cervical cancer and is an underlying biomarker for cervical squamous cell carcinoma.

Indexed as

Carcinoma, Squamous CellMicroRNAsUterine Cervical NeoplasmsFemaleHumansRNA, CircularRNA, MessengerMicroRNAsMIRN154 microRNA, humanRNA, CircularRNA, MessengerCervical cancerCompeting endogenous RNAHuman papillomavirusImmune infiltrationmiR-154-5pPrognosis

Identifiers

PMID36894874
PMCPMC9999601
OpenAlexW4323655223

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.